Consider adding a smart lamp to your shopping list. While these products will illuminate a dark space just like a traditional lamp, they're packed with additional features – such as the option ...

When you purchase through links on our site, we may earn an affiliate commission. Good lighting at home can be transformative, whether that’s stringing up fairy lights in the bedroom ...

In this article we delve into the evidence for SAD lamps with the help of one of Which?'s expert scientific advisors, Ruby Gordon, along with insights from The Royal College of Psychiatrists (RCP) and ...

Trade war with China? Check. Cuts to scientific research? Check.

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

RBC Capital reiterated an Outperform rating and $247 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its sequencing by extension technology, with initial ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...